Origin and Molecular Targets
Caffeine is the most potent CNS stimulant among the methylxanthines (which also include theobromine and theophylline). In nature, it is found in tea leaves, coffee beans, cocoa beans, cola nuts, and certain other plants.
At the cellular level, the alkaloid acts via three primary biochemical mechanisms:
- Adenosine receptor blockade. This is the primary modern theory of its action. Endogenous adenosine normally exerts a protective function: it accumulates during hypoxia and stimulates receptors, causing cell hyperpolarization and inhibition (protecting the brain and myocardium). Caffeine acts as a competitive antagonist—blocking these receptors, removing the inhibitory tone of adenosine, and activating the cells.
- Phosphodiesterase (PDE) inhibition. The drug inhibits this enzyme, slowing down the degradation of cyclic adenosine monophosphate (cAMP). As a result, cAMP accumulates in high concentrations in the tissues of the brain, heart, and other organs.
- Calcium modulation. It alters intracellular $Ca^{2+}$ ion levels.
CNS and Cardiac Effects
The pharmacological action of caffeine often represents a balance between its central and peripheral effects.
- Central Nervous System. It exerts a potent psychostimulatory effect by stimulating the cerebral cortex. This manifests as reduced fatigue, decreased sleep propensity, and increased mental and physical performance. However, the outcome heavily depends on the individual's higher nervous activity (HNA) type. Patients with a weak HNA type may experience enhanced inhibition and drowsiness instead of excitation. Additionally, caffeine has an analeptic effect—stimulating vital centers in the medulla oblongata (respiratory and vasomotor centers).
- Cardiac Activity. Here, two opposing influences collide. A direct (peripheral) action on the myocardium tends to cause tachycardia. A central action (stimulation of the vagus nerve nuclei, n. vagus) tends to cause bradycardia. The net result depends on which component predominates. Higher doses typically result in a dominant peripheral effect: tachycardia develops, myocardial oxygen demand increases, and the risk of triggering dangerous arrhythmias rises.
Effects on Vessels, Blood Pressure, and Other Organs
Its effect on vascular tone is complex and varies by vascular bed, resulting from central vasomotor center stimulation (vasoconstriction) combined with direct myotropic spastolytic action on smooth muscle (vasodilation).
- Dilated vessels: Coronary arteries of the heart and renal arteries.
- Constricted vessels: Abdominal cavity blood vessels (except for the kidneys).
- Cerebral blood vessels: Caffeine tonifies and constricts them, particularly if they are pathologically dilated. This specific property underlies the drug's clinical efficacy in migraines—it relieves headaches of vascular origin.
- Blood Pressure: In hypotension, the alkaloid raises blood pressure via direct stimulation of the vasomotor center, helping to normalize it. In normotensive individuals, it produces little to no change in blood pressure.
- Other organs: It exerts a myotropic antispasmodic effect on smooth muscle (e.g., bronchodilation). In the kidneys, it causes a moderate increase in diuresis due to renal vessel dilation and the inhibition of tubular electrolyte reabsorption.
Clinical Use and Safety Profile
In clinical practice, caffeine is used as caffeine sodium benzoate (tablets and parenteral solutions) and is included in numerous combination formulations.
Indications for Use:
- Monotherapy: To enhance performance, combat fatigue and somnolence, and correct hypotensive states.
- Combination therapy: For migraines, it is combined with ergot alkaloids. It also potentiates non-narcotic analgesics-antipyretics and is a component of common combination analgesics and cold medications.
Safety Profile:
- Side effects: CNS effects include insomnia, anxiety, and psychomotor agitation. GI effects include nausea and vomiting. The cardiovascular system may respond with tachycardia and arrhythmias. Prolonged use leads to tolerance and specific drug dependence—caffeinism.
- Contraindications: Severe arterial hypertension, advanced atherosclerosis, glaucoma, and severe insomnia.